Lucia Ricciardi

Dr. Lucia Ricciardi

St George's University of London

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LRLucia Ricciardi
Lucia Ricciardi
FVFederica Visco-Comandini
Federica Visco-Comandini
RERoberto Erro
Roberto Erro
FMFrancesca Morgante
Francesca Morgante
Matteo BolognaMatteo Bologna
Matteo Bologna
JKJames Kilner
James Kilner
Parkinson’s disease (PD) patients have impairment of facial expressivity (hypomimia) and difficulties in interpreting the emotional facial expressions produced by others, especially for aversive emotions. We aimed to evaluate the ability to produce facial emotional expressions and to recognize facial emotional expressions produced by others in a group of PD patients and a group of healthy participants in order to explore the relationship between these two abilities and any differences between the two groups of participants. Twenty non-demented, non-depressed PD patients and twenty healthy participants (HC) matched for demographic characteristics were studied. The ability of recognizing emotional facial expressions was assessed with the Ekman 60-faces test (Emotion recognition task). Participants were video-recorded while posing facial expressions of 6 primary emotions (happiness, sadness, surprise, disgust, fear and anger). The most expressive pictures for each emotion were derived from the videos. Ten healthy raters were asked to look at the pictures displayed on a computer-screen in pseudo-random fashion and to identify the emotional label in a six-forced-choice response format (Emotion expressivity task). Reaction time (RT) and accuracy of responses were recorded. At the end of each trial the participant was asked to rate his/her confidence in his/her perceived accuracy of response. For emotion recognition, PD reported lower score than HC for Ekman total score (p<0.001), and for single emotions sub-scores happiness, fear, anger, sadness (p<0.01) and surprise (p = 0.02). In the facial emotion expressivity task, PD and HC significantly differed in the total score (p = 0.05) and in the sub-scores for happiness, sadness, anger (all p<0.001). RT and the level of confidence showed significant differences between PD and HC for the same emotions. There was a significant positive correlation between the emotion facial recognition and expressivity in both groups; the correlation was even stronger when ranking emotions from the best recognized to the worst (R = 0.75, p = 0.004). PD patients showed difficulties in recognizing emotional facial expressions produced by others and in posing facial emotional expressions compared to healthy subjects. The linear correlation between recognition and expression in both experimental groups suggests that the two mechanisms share a common system, which could be deteriorated in patients with PD. These results open new clinical and rehabilitation perspectives.

1 November 2015 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
LRLucia Ricciardi
Lucia Ricciardi
Matteo BolognaMatteo Bologna
Matteo Bologna
FMFrancesca Morgante
Francesca Morgante
DRDiego Ricciardi
Diego Ricciardi
BMBruno Morabito
Bruno Morabito
Alfonso FasanoAlfonso Fasano
Alfonso Fasano

23 July 2020 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
LRLucia Ricciardi
Lucia Ricciardi
AAA. De Angelis
A. De Angelis
LML. Marsili
L. Marsili
IFI. Faiman
I. Faiman
PPP. Pradhan
P. Pradhan
Matteo BolognaMatteo Bologna
Matteo Bologna
Background and purpose: Hypomimia is a prominent clinical feature in people with Parkinson’s disease (PD), but it remains under‐investigated. We aimed to examine the clinical correlates of hypomimia in PD and to determine whether this is a levodopa‐responsive sign.Methods: We included 89 people with PD. Hypomimia was assessed from digital video recordings by movement disorder specialists. Clinical evaluation included use of the Unified Parkinson’s Disease Rating Scale part III (UPDRS‐III), and assessment of motor and non‐motor symptoms using standardized clinical scales. The relationships between hypomimia and other clinical data were analysed using Mann–Whitney U‐tests and regression analysis.Results: Hypomimia occurred in up to 70% of patients with PD. Patients with hypomimia had worse UPDRS‐III 'off‐medication' scores, mainly driven by bradykinesia and rigidity subscores. Patients with hypomimia also had worse apathy than patients without hypomimia. Finally, we found that hypomimia was levodopa‐responsive and its improvement mirrored the change by levodopa in axial motor symptoms.Conclusion: Our study provides novel information regarding the clinical correlates of hypomimia in people with PD. A better understanding of hypomimia may be relevant for improving treatment and quality of life in PD.

18 November 2012 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
ABAnna Rita Bentivoglio
Anna Rita Bentivoglio
EBEleonora Baldonero
Eleonora Baldonero
LRLucia Ricciardi
Lucia Ricciardi
FNFrancesca De Nigris
Francesca De Nigris
ADAntonio Daniele
Antonio Daniele

25 November 2019 in Sensors
Verified
Journal Article
Open access
PDF file
HKHamid Khodakarami
Hamid Khodakarami
LRLucia Ricciardi
Lucia Ricciardi
MCMaria Fiorella Contarino
Maria Fiorella Contarino
RPRajesh Pahwa
Rajesh Pahwa
KLKelly E. Lyons
Kelly E. Lyons
MHMalcolm Horne
Malcolm Horne
The response to levodopa (LR) is important for managing Parkinson’s Disease and is measured with clinical scales prior to (OFF) and after (ON) levodopa. The aim of this study was to ascertain whether an ambulatory wearable device could predict the LR from the response to the first morning dose. The ON and OFF scores were sorted into six categories of severity so that separating Parkinson’s Kinetigraph (PKG) features corresponding to the ON and OFF scores became a multi-class classification problem according to whether they fell below or above the threshold for each class. Candidate features were extracted from the PKG data and matched to the class labels. Several linear and non-linear candidate statistical models were examined and compared to classify the six categories of severity. The resulting model predicted a clinically significant LR with an area under the receiver operator curve of 0.92. This study shows that ambulatory data could be used to identify a clinically significant response to levodopa. This study has also identified practical steps that would enhance the reliability of this test in future studies.

1 May 2021 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
LRLucia Ricciardi
Lucia Ricciardi
VNVeronica Nisticò
Veronica Nisticò
EAElisa Andrenelli
Elisa Andrenelli
JCJoana Macedo Cunha
Joana Macedo Cunha
BDBenedetta Demartini
Benedetta Demartini
MEMark J. Edwards
Mark J. Edwards